Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 10 Jul 2026 for AKTIS ONCOLOGY, INC., €160k.
Filing timeline
BuySaleShulamit Ron-Bigger
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Shulamit Ron-Bigger: trading record in brief
All filings by Shulamit Ron-Bigger on record concern Aktis Oncology, Inc. Activity is concentrated on a single trading day, 8 July 2026, with 4 filings.
Every open-market trade on record is a sale: 3 sales worth €1.2M. Other entries cover 1 option exercise.
The newest entry dates from 10 July 2026: an open-market sale of €735k, in Aktis Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shulamit Ron-Bigger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
50,000 shares@ US$3.66Common StockSEC:0001193125-26-300163:0
15,800 shares@ US$27.1317Common StockSEC:0001193125-26-300163:1
30,000 shares@ US$27.9379Common StockSEC:0001193125-26-300163:2
4,200 shares@ US$28.7476Common StockSEC:0001193125-26-300163:3
4 of 4 declarations
